Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tim Chiang's Stock Ratings
Capital One Analyst
Tim Chiang is an analyst at Capital One. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
-5.65%
Smart Score
Overall Average Return Percentile
31st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2024 | HRTX | Buy Now | Heron Therapeutics | $2.15 | 179.07% | Tim Chiang39% | → $6 | Initiates | → Overweight | Get Alert |
| 10/30/2023 | PTGX | Buy Now | Protagonist Therapeutics | $46.16 | — | Tim Chiang39% | — | Initiates | → Overweight | Get Alert |
| 08/11/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.56 | 53.51% | Tim Chiang39% | → $70 | Initiates | → Overweight | Get Alert |
| 07/29/2022 | AMPH | Buy Now | Amphastar Pharma | $24.00 | 83.33% | Tim Chiang39% | → $44 | Initiates | → Overweight | Get Alert |
| 03/30/2022 | KALA | Buy Now | Kala Pharmaceuticals | $2.95 | 35.7% | Tim Chiang39% | $300 → $200 | Maintains | Outperform | Get Alert |
| 03/21/2022 | OACB | Buy Now | Oaktree Acquisition | — | — | Tim Chiang39% | → $15 | Initiates | → Outperform | Get Alert |
| 02/07/2022 | CYT | Buy Now | Cyteir Therapeutics | — | — | Tim Chiang39% | → $16 | Initiates | → Outperform | Get Alert |
| 10/11/2021 | PTGX | Buy Now | Protagonist Therapeutics | $46.16 | -13.34% | Tim Chiang39% | → $40 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/04/2021 | BCYP | Buy Now | Big Cypress Acquisition | — | — | Tim Chiang39% | → $18 | Initiates | → Outperform | Get Alert |
| 09/14/2021 | ISR | Buy Now | Isoray | — | — | Tim Chiang39% | → $1.25 | Initiates | → Outperform | Get Alert |
| 05/24/2021 | PTGX | Buy Now | Protagonist Therapeutics | $46.16 | -9.01% | Tim Chiang39% | → $42 | Initiates | → Outperform | Get Alert |
| 05/05/2021 | PCRX | Buy Now | Pacira BioSciences | $24.22 | 172.5% | Tim Chiang39% | $75 → $66 | Maintains | Market Perform | Get Alert |
| 10/28/2020 | RPTX | Buy Now | Repare Therapeutics | $1.35 | — | Tim Chiang39% | — | Initiates | → Outperform | Get Alert |
| 09/21/2020 | PCRX | Buy Now | Pacira BioSciences | $24.22 | 176.63% | Tim Chiang39% | $58 → $67 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/23/2020 | KALA | Buy Now | Kala Pharmaceuticals | $2.95 | 476.72% | Tim Chiang39% | → $850 | Initiates | → Outperform | Get Alert |
| 07/09/2020 | AMPH | Buy Now | Amphastar Pharma | $24.00 | -4.17% | Tim Chiang39% | → $23 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/24/2020 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.44 | 4623.35% | Tim Chiang39% | → $21 | Initiates | → Outperform | Get Alert |
| 04/07/2020 | PCRX | Buy Now | Pacira BioSciences | $24.22 | 106.44% | Tim Chiang39% | → $50 | Initiates | → Outperform | Get Alert |
| 09/17/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | — | Tim Chiang39% | — | Upgrade | Sell → Neutral | Get Alert |
| 02/13/2018 | SMMT | Buy Now | Summit Therapeutics | $33.11 | -0.33% | Tim Chiang39% | → $33 | Initiates | → Buy | Get Alert |
| 01/18/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | — | Tim Chiang39% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/16/2018 | TIG | Buy Now | Trean Insurance Group | — | — | Tim Chiang39% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/11/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | 66.9% | Tim Chiang39% | → $24 | Upgrade | Neutral → Buy | Get Alert |
| 11/16/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | — | Tim Chiang39% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/24/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | 421.56% | Tim Chiang39% | → $75 | Maintains | Buy | Get Alert |
| 07/07/2015 | TEVA | Buy Now | Teva Pharmaceutical Indus | $14.38 | 435.47% | Tim Chiang39% | → $77 | Initiates | → Buy | Get Alert |
